date founded

Financing round

General

About Company
Exemplify BioPharma is a provider of integrated CMC management and functional support services for drug developers.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2015

Number of employees

Company Type

For Profit

IPO status

Private

Description

Exemplify BioPharma offers end-to-end CMC drug development services to pharmaceutical and biotech partners, helping them successfully navigate the challenges of drug development. Their services include process chemistry, analytical chemistry, formulation development, and CMC regulatory filing documentation. Additionally, they provide program management, consulting, and API and CTM supply management services. With a focus on partnership and collaboration, Exemplify BioPharma targets mid-sized pharmaceutical and biotech companies, as well as virtual and international pharmaceutical ventures looking to establish capabilities in the US.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Pacific Biodevelopment

Pacific Biodevelopment

Pacific BioDevelopment offers strategic drug development services for pharmaceutical and biotech companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Davis, CA, USA
KLIFO

KLIFO

KLIFO is a drug development consulting firm that partners with biotech and pharmaceutical companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Pharmaceuticals, Biotechnology, Consulting

Location

2600 Glostrup, Denmark
NGT BioPharma Consultants

NGT BioPharma Consultants

NGT Biopharma Consultants provides strategic and operational consultancy for the development of small molecule and biologic drug candidates.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Consulting, Pharmaceuticals
Probiocon

Probiocon

Probiocon is a consulting company that offers comprehensive services for pharmaceutical and biotechnological companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

count Of Investments

2
M&A Details
1

Transaction name

Acquired by

Syncom

announced date

25.10.2022

Financials

Co-Investors

People

Employee Profiles
2

Alexander Korotkov

Senior process chemist

John Bolesta

Vice president, partner relations

Activity

Recent News
0